Demant: Cochlear acquires Demant's hearing implant business after clearing competition hurdles

Cochlear (ASX: COH) has completed its buyout of the hearing implant operations of Danish competitor Oticon Medical from parent company Demant after the deal was cleared by the Australian competition watchdog last month. The acquisition, which initially comprised a $170 million takeover of Oticon Medical, was revised to just include the target&r...